To evaluate the risk factors influencing non-SLN spread among different clinicopathological traits by multivariate analysis, the patients’ age, tumor size, histologic grade, LVI, ER, PR, HER2 and Ki67 index, and the number of SLNs+, SLNs and non-SLNs were used. This evidence concerns the gene ERBB2 and neoplasm.